Imaging Core
成像核心
基本信息
- 批准号:10060458
- 负责人:
- 金额:$ 21.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-01 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:AdhesivesBenignBiologicalCell CycleCellsChargeComplementComplexDataData AnalysesEducational workshopElectron MicroscopyEnsureEquipmentEventFlow CytometryFluorescenceFluorescence-Activated Cell SortingFundingHematologyHematopoiesisHematopoieticHome environmentImageImage CytometryImaging TechniquesIndividualKnowledgeLaboratoriesLightMeasurementMicroscopyMolecularMouse StrainsOpticsPhototoxicityPositioning AttributePreparationProcessPropertyReagentReporterResearchResearch PersonnelResearch Project GrantsResolutionSamplingScientistServicesSignal TransductionSpecialistStructureStudentsTechnical ExpertiseTechniquesTimeTissuesTrainingcareercell typecellular imagingdesignfluorescence imaginggenetic manipulationhematopoietic tissueimaging approachimaging facilitiesimaging modalityimaging platformincentive programinnovationinstrumentinstrumentationinterestlive cell microscopymembermicroscopic imagingnoveloperationpreferenceprogramspsychologicsymposiumtooltwo-photon
项目摘要
Project Summary
Yale Cooperative Center of Excellence in Hematology
Imaging Core
The Imaging Core of the YCCEH has provided access to state-of-the-art microscopy for benign hematology to
progressively more users each year. In this renewal, we propose to continue operations with enhancements
including longterm timelapse with decreased phototoxicity, adapted super resolution imaging for hematopoietic
tissues and automated high-throughput microscopy for imaging of 1,000 to 10,000 cells/24 hrs at super-
resolution. Hematopoiesis is a complex and dynamic process involving many heterologous cell types. Due to
the rich spatial and/or temporal information contained in imaging data, imaging is uniquely powerful in
revealing the influences of cellular dynamics and tissue organization on the relevant cells and states. As many
hematopoietic cells are small in size, minimally adhesive, difficult to manipulate genetically, reside in deep
tissues, highly dynamic and/or exceedingly rare, the ability to apply imaging approaches to hematopoiesis
research has been limited to few laboratories with the requisite technical expertise and instrumentation.
YCCEH Imaging Core aims to reduce the high technical hurdle and promote the application of imaging
techniques for hematopoietic research. Yale is the home of many state-of-the-art imaging equipment and
facilities overseen by world-renowned leaders and experts in microscopy. The YCCEH Imaging Core will make
the large array of imaging platforms readily accessible to all investigators with a research interest in
hematopoiesis, locally or nationally. YCCEH Imaging Core will continue to provide its members with access to
state-of-the-art instrumentation including widefield, confocal, 2-photon and flow cytometry imaging. Importantly,
through this Imaging Core, we are making it available as a service, access to and expertise in using innovative
imaging modalities including automated long-term live-cell time-lapse microscopy, optical clearing of tissue and
super-resolution microscopy. The directors of the Core, Drs. Bewersdorf and Guo will act as liaisons between
YCCEH members and the participating facilities and labs and will help identifying most suitable techniques for
individual research projects. The Imaging Core will also support two part time imaging specialists who will train
YCCEH members, maintain the instruments provided by the Bewersdorf and Guo labs and assist with
reagents, sample preparation and data analysis. We will continue to promote the dissemination of knowledge
for imaging in hematopoietic research by organizing symposia, workshops, seminars and training with an
emphasis on students, trainees and other early-stage investigators. Furthermore, the Imaging Core will
continue to develop, optimize and disseminate innovative reporters/probes that are suitable for analyzing
hematopoietic cells by fluorescence imaging and/or flow cytometry. We will continue to encourage YCCEH
members to evaluate various microscopy techniques for their research projects through the user incentive
program, by eliminating the psychological hurdle of investing funds into an unfamiliar technical domain.
Overall, the Imaging Core will facilitate and enable individual hematopoietic researchers to make observations
of their specific hematopoietic cell linages, using approaches that can provide unique structural, functional
and/or dynamic information.
项目摘要
耶鲁大学血液学卓越合作中心
成像核心
YCCEH的成像核心为良性血液学提供了最先进的显微镜技术
每年都有越来越多的用户。在此次续订中,我们建议通过增强功能继续运营
包括光毒性降低的长期时间流逝,适用于造血的超分辨率成像
组织和自动化高通量显微镜,用于在24小时内对1,000至10,000个细胞进行成像
决议。造血是一个复杂而动态的过程,涉及多种异种细胞类型。由于
成像数据中包含丰富的空间和/或时间信息,成像在以下方面具有独特的强大功能
揭示细胞动力学和组织结构对相关细胞和状态的影响。同样多的人
造血细胞体积小,粘附性小,很难从基因上进行操作,存在于深部
高度动态的和/或极其罕见的组织,能够将成像方法应用于造血
研究一直局限于拥有必要技术专长和仪器的少数几个实验室。
YCCEH影像芯旨在降低高技术门槛,推动影像应用
造血研究的技术。耶鲁大学是许多最先进的成像设备和
由世界知名的显微镜领导者和专家监督的设施。YCCEH成像核心将使
所有有研究兴趣的研究人员都可以很容易地接触到大量的成像平台
地方性或全国性的造血。YCCEH影像核心将继续为其成员提供访问
最先进的仪器,包括广域成像、共焦成像、双光子成像和流式细胞术成像。重要的是
通过这一成像核心,我们正在将其作为一项服务提供,并在使用创新技术方面提供访问和专业知识
成像方式包括自动长期活细胞延时显微镜,组织的光学清除和
超分辨率显微镜。CORE的董事、比尔斯多夫博士和郭博士将担任
YCCEH成员和参与的设施和实验室,并将帮助确定最适合的技术
个人研究项目。成像核心还将支持两名兼职成像专家,他们将接受培训
YCCEH成员,维护比尔斯多夫和郭实验室提供的仪器并协助
试剂、样品制备和数据分析。我们将继续推动知识的传播
通过组织研讨会、讲习班、研讨会和培训,在造血研究中进行成像
侧重于学生、实习生和其他早期调查人员。此外,成像核心将
继续开发、优化和传播适合分析的创新型记者/探头
通过荧光成像和/或流式细胞术检测造血细胞。我们会继续鼓励基督教青年会
会员通过用户激励对其研究项目的各种显微技术进行评估
计划,通过消除将资金投资于一个陌生的技术领域的心理障碍。
总体而言,成像核心将促进并使单个造血研究人员能够进行观察
利用能够提供独特的结构、功能的方法
和/或动态信息。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joerg Bewersdorf其他文献
Joerg Bewersdorf的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joerg Bewersdorf', 18)}}的其他基金
Development of a Versatile Multiplexing Nanoscopy Platform for Cell Biology
细胞生物学多功能多重纳米显微镜平台的开发
- 批准号:
10753760 - 财政年份:2023
- 资助金额:
$ 21.96万 - 项目类别:
Development of pan-Expansion Microscopy to reveal mechanisms underlying epidermal differentiation
开发泛膨胀显微镜以揭示表皮分化的机制
- 批准号:
10662553 - 财政年份:2022
- 资助金额:
$ 21.96万 - 项目类别:
Development of pan-Expansion Microscopy to reveal mechanisms underlying epidermal differentiation
开发泛膨胀显微镜以揭示表皮分化的机制
- 批准号:
10539999 - 财政年份:2022
- 资助金额:
$ 21.96万 - 项目类别:
An Integrated Imaging System for High-throughput Nanoscopy of the 4D Nucleome
用于 4D 核组高通量纳米显微成像的集成成像系统
- 批准号:
9308968 - 财政年份:2015
- 资助金额:
$ 21.96万 - 项目类别:
相似海外基金
Genome analysis-based prediction model development for response to stereotactic radiosurgery in benign brain tumors
基于基因组分析的预测模型开发,用于良性脑肿瘤立体定向放射外科治疗的反应
- 批准号:
23K08495 - 财政年份:2023
- 资助金额:
$ 21.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Clinical breast cancer risk prediction models for women with a high-risk benign breast diagnosis
高风险良性乳腺诊断女性的临床乳腺癌风险预测模型
- 批准号:
10719777 - 财政年份:2023
- 资助金额:
$ 21.96万 - 项目类别:
Environmentally Benign Precise Transformations of Alkenes by Chiral Chalcogenide Catalysts
手性硫属化物催化剂对环境无害的烯烃精确转化
- 批准号:
22KJ2498 - 财政年份:2023
- 资助金额:
$ 21.96万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Learners to LeAders in benign Urology, benign Nephrology, and non-Cancer Hematology
良性泌尿外科、良性肾脏病学和非癌症血液学领域的学习者和领导者
- 批准号:
10726042 - 财政年份:2023
- 资助金额:
$ 21.96万 - 项目类别:
The role of estrogen receptor alpha in prostatic fibrosis contributing to benign prostatic hyperplasia
雌激素受体α在导致良性前列腺增生的前列腺纤维化中的作用
- 批准号:
10607151 - 财政年份:2023
- 资助金额:
$ 21.96万 - 项目类别:
Development of a medical device to resolve benign esophageal stricture by heating and traction
开发通过加热和牵引解决良性食管狭窄的医疗设备
- 批准号:
23H03765 - 财政年份:2023
- 资助金额:
$ 21.96万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of benign/malignant differentiation method for thyroid follicular tumor using organoids
利用类器官开发甲状腺滤泡性肿瘤良恶性鉴别方法
- 批准号:
23K08075 - 财政年份:2023
- 资助金额:
$ 21.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanisms of p53 Engagement and Action at the Benign-to-Malignant Transition in Sporadic Tumorigenesis
p53在散发性肿瘤发生良性向恶性转变中的参与和作用机制
- 批准号:
10720034 - 财政年份:2023
- 资助金额:
$ 21.96万 - 项目类别:
I-Corps: Mitigating Multidrug Resistant Bacterial Infections with Biocompatible and Environmentally Benign Nanoantibiotics
I-Corps:利用生物相容性且对环境无害的纳米抗生素减轻多重耐药细菌感染
- 批准号:
2306943 - 财政年份:2023
- 资助金额:
$ 21.96万 - 项目类别:
Standard Grant
Identifying the role of the gut microbiome in the etiology of benign breast disease
确定肠道微生物组在良性乳腺疾病病因学中的作用
- 批准号:
10359959 - 财政年份:2022
- 资助金额:
$ 21.96万 - 项目类别: